Help
Subscribe


All of GastroHep is now free access! - Click here to register Read For FREE - Our full range of review articles
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Guido Tytgat Profile of Pete Peterson Profile of Peter Cotton Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Post-transplant lymphoproliferative risk in pancreas recipients

Post-transplant lymphoproliferative in pancreas recipients has a worse prognosis than in other transplant recipients, and these immunosuppressed patients, who often face multiple transplants, may be at greater risk, reports the latest Transplantation.

News image

Post-transplant lymphoproliferative disorder is a rare, serious complication of transplantation.

The characteristics and associations of this disease in pancreas recipients have not been extensively studied.

Dr Steven Paraskevas and colleagues performed 787 pancreas and 569 kidney-pancreas transplants from 1988 to 2002 at their institution.

The research team reported that 18 pancreas recipients developed polymorphic posttransplant lymphoproliferative disorder or malignant lymphoma.

Data on clinical course, organ involvement, molecular characteristics was compiled from the institutional transplant database

Cytomegalovirus infection may play an antecedent role
Transplantation

The researchers also compiled data on and association with immunosuppression and recent cytomegalovirus infection.

Patient survival was compared to recipients of liver and kidney transplants at the same center by using Kaplan-Meier analysis.

The researchers found that the 5-year cumulative incidence of posttransplant lymphoproliferative in simultaneous pancreas-kidney recipients was 3%.

The 5-year cumulative incidence of post-transplant lymphoproliferative in pancreas after kidney recipients was 1.2%.

In pancreas transplant alone recipients, the 5-year cumulative incidence of the disease was 1%.

The team noticed a higher, but not significant, cumulative incidence in the more recent era since 1995.

Post-transplant lymphoproliferative in pancreas recipients carried a worse prognosis than in liver or kidney for recipients B-cell.

The researchers also observed that Post-transplant lymphoproliferative had a worse prognosis with early-onset, and Epstein Barr virus-positive lesions.

Posttransplant lymphoproliferative was more aggressive in pancreas recipients, with a higher stage at presentation and a trend to more bone marrow involvement.

The research team noted a tendency toward association with recent cytomegalovirus infection.

Since 1995, the team observed that post-transplant lymphoproliferative recipients have had a lower exposure to antilymphocyte preparations.

Dr Paraskevas' team concludes, “Posttransplant lymphoproliferative in pancreas recipients remains a rare but aggressive disease, and carries a worse prognosis in comparison to other transplant recipients.”

“These heavily immunosuppressed patients, who often face multiple transplants, may be at greater risk; cytomegalovirus infection may play an antecedent role.”

Transpl 2005: 80(5) 613-22
22 September 2005

Go to top of page Email this page Email this page to a colleague

 26 April 2015

Advanced search
 24 April 2015 
GastroHep.com Easter break
 23 April 2015 
Gut microbiota modulation for alcoholic liver disease
 23 April 2015 
Moderate sodium restriction diet in cirrhosis
 23 April 2015 
Gastroesophageal junction disruption and obesity
 22 April 2015 
Hepatitis and mortality in hospitalized patients
 22 April 2015 
Magnetic sphincter augmentation for GERD
 22 April 2015 
Drug, herbal and dietary supplement hepatotoxicity
 21 April 2015 
Risk factors of postpartum bowel changes
 21 April 2015 
Tracking colonoscopy surveillance intervals
 21 April 2015 
PPI increases risk of cryptogenic liver abscess
 20 April 2015 
IBS after traveller's diarhea
 20 April 2015 
Economic impact of C. diff infection
 20 April 2015 
Adherence to Hep C treatments
 17 April 2015 
Synchronous colorectal advanced neoplasia
 17 April 2015 
PNPLA3 polymorphisms and NAFLD risk
 17 April 2015 
MELD score and colorectal resection
 16 April 2015 
Bleeding risk in colonic diverticulosis
 16 April 2015 
Minority use of high-volume hospitals for colorectal cancer
 16 April 2015 
Sleep and IBD
 15 April 2015 
Treatment of hepatocellular carcinoma
 15 April 2015 
Score predicts malignant bile duct obstruction
 15 April 2015 
Increased risk of Barrett esophagus
 14 April 2015 
Improving colorectal cancer screening uptake
 14 April 2015 
Colorectal cancer presenting under the age of 50
 14 April 2015 
Functional constipation vs constipation predominant IBS
 13 April 2015 
Fecal transplant for C. difficile
 13 April 2015 
Immune based treatments for HCC
 13 April 2015 
CRP and acute diverticulitis
 10 April 2015 
Hypnotherapy for IBS
 10 April 2015 
Adjuvant therapy after rectal cancer
 10 April 2015 
Viral outcomes in HCV infection
 09 April 2015 
Male IBD patients wishing to conceive
 09 April 2015 
Screening programs based on the fecal immunochemical test
 09 April 2015 
Management of esophageal food impaction
 08 April 2015 
Nonceliac gluten sensitivity
 08 April 2015 
Ambulatory hemorrhoidal surgery
 08 April 2015 
Iron fortification and gut inflammation
 07 April 2015 
Endoscopic managements of GI bleeds
 07 April 2015 
Interventions for eosinophilic esophagitis
 07 April 2015 
Treatment of Hep C virus
 06 April 2015 
Treatment for rectal cancer
 06 April 2015 
Risk stratifying Barrett's esophagus
 06 April 2015 
Cost-effectiveness of HCV
 03 April 2015 
Predicting advanced cancer in Barrett's
 03 April 2015 
Vitamin D deficiency and Hep B outcomes
 03 April 2015 
Hepatocellular carcinoma surveillance in cirrhosis
 02 April 2015 
Physical activity and NAFLD
 02 April 2015 
Genetic risk for Crohn's disease
 02 April 2015 
EUS for detection of pancreatic neuroendocrine tumors
 01 April 2015 
Analysis of liver fibrosis
 01 April 2015 
Obeticholic acid in primary biliary cirrhosis
 01 April 2015 
Mortality rates for upper GI bleeds
 31 March 2015 
HCV-HIV co-infection combination therapy
 31 March 2015 
Placement of nasoenteral feeding tubes
 31 March 2015 
Hepatic fat and gallbladder polyps
 30 March 2015 
Minimally invasive approach in colorectal procedures
 30 March 2015 
Prevalence of IBD in USA residents of Indian ancestry
 30 March 2015 
Treatment of pediatric IBD
 27 March 2015 
Screening for fecal incontinence
 27 March 2015 
Deep remission in Crohn's disease

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2015 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us